{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:39:22Z","timestamp":1790782762668,"version":"4.1.0"},"reference-count":276,"publisher":"Elsevier","isbn-type":[{"value":"9780128171790","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.acc.2019.01.002","type":"book-chapter","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T08:45:13Z","timestamp":1551775513000},"page":"25-80","source":"Crossref","is-referenced-by-count":151,"title":["Acute phase reactant serum amyloid A in inflammation and other diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2019.01.002_bb0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI107985","article-title":"Variation with age and disease of an amyloid A protein-related serum component","volume":"55","author":"Rosenthal","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jcp.39.6.635","article-title":"Serum amyloid A concentrations during the course of acute ischaemic heart disease","volume":"39","author":"Shainkin-Kestenbaum","year":"1986","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4049\/jimmunol.169.1.399","article-title":"Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2","volume":"169","author":"Thorn","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/dna.1991.10.651","article-title":"Nonexpression of the human serum amyloid A three (SAA3) gene","volume":"10","author":"Kluve-Beckerman","year":"1991","journal-title":"DNA Cell Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0030","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0006-291X(03)00045-7","article-title":"Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide","volume":"301","author":"Larson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb0035","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/S0021-9258(19)50605-6","article-title":"Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein","volume":"267","author":"Whitehead","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-2275(20)39886-2","article-title":"Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein","volume":"36","author":"de Beer","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/0006-291X(86)90352-9","article-title":"Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms","volume":"137","author":"Kluve-Beckerman","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1994.1051","article-title":"The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis","volume":"19","author":"Sellar","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/bs.acc.2019.01.002_bb0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/geno.1994.1052","article-title":"Evolution of the serum amyloid A (SAA) protein superfamily","volume":"19","author":"Uhlar","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/bs.acc.2019.01.002_bb0060","doi-asserted-by":"crossref","first-page":"18368","DOI":"10.1016\/S0021-9258(18)51473-3","article-title":"Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci","volume":"264","author":"Strachan","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0167-5699(94)90138-4","article-title":"The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein","volume":"15","author":"Steel","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/bs.acc.2019.01.002_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-2427(01)00380-4","article-title":"Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrum","volume":"83","author":"McDonald","year":"2001","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0075","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/geno.1993.1209","article-title":"A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2)","volume":"16","author":"Steel","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/bs.acc.2019.01.002_bb0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0085","first-page":"1908","article-title":"Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kappaB-like transcription factor","volume":"9","author":"Edbrooke","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0090","first-page":"4324","article-title":"Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C\/EBP-beta and C\/EBP-delta and their activation by phosphorylation","volume":"14","author":"Ray","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0095","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1021\/bi9624595","article-title":"Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte\/macrophage cells by lipopolysaccharide","volume":"36","author":"Ray","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/bs.acc.2019.01.002_bb0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3083.1988.tb01455.x","article-title":"Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits","volume":"28","author":"Tape","year":"1988","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0105","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1161\/01.CIR.96.9.2914","article-title":"Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes","volume":"96","author":"Fyfe","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2019.01.002_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/13506129909007327","article-title":"Serum amyloid A1 alleles and plasma concentrations of serum amyloid A","volume":"6","author":"Yamada","year":"1999","journal-title":"Amyloid"},{"key":"10.1016\/bs.acc.2019.01.002_bb0115","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1021\/bi00257a008","article-title":"Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein","volume":"21","author":"Parmelee","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/bs.acc.2019.01.002_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/abbi.1993.1296","article-title":"A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57","volume":"303","author":"Baba","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"issue":"Pt 2","key":"10.1016\/bs.acc.2019.01.002_bb0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/bj2820615","article-title":"Human serum amyloid A protein. Complete amino acid sequence of a new variant","volume":"282","author":"Beach","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/bs.acc.2019.01.002_bb0130","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0006-291X(91)92051-K","article-title":"Characterization of an isoelectric focusing variant of SAA1 (ASP-72) in a family of Turkish origin","volume":"181","author":"Kluve-Beckerman","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb0135","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/bi00405a044","article-title":"Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual","volume":"27","author":"Dwulet","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/bs.acc.2019.01.002_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/13506120903421546","article-title":"Differential affinity of serum amyloid A1 isotypes for high-density lipoprotein","volume":"16","author":"Yamada","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/bs.acc.2019.01.002_bb0145","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","article-title":"Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2019.01.002_bb0150","first-page":"387","article-title":"Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites","volume":"3","author":"Turnell","year":"1986","journal-title":"Mol. Biol. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118835","article-title":"Human serum amyloid A3 (SAA3) protein, expressed as a fusion protein with SAA2, binds the oxidized low density lipoprotein receptor","volume":"10","author":"Tomita","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb0160","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1016\/S0021-9258(19)83932-7","article-title":"Structure of the murine serum amyloid A gene family. Gene conversion","volume":"261","author":"Lowell","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0165","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1084\/jem.164.6.2006","article-title":"Amyloid A gene family expression in different mouse tissues","volume":"164","author":"Meek","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0170","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1292\/jvms.14-0007","article-title":"Up-regulation of MUC2 mucin expression by serum amyloid A3 protein in mouse colonic epithelial cells","volume":"76","author":"Shigemura","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/bs.acc.2019.01.002_bb0175","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1194\/jlr.M005413","article-title":"Impact of serum amyloid A on high density lipoprotein composition and levels","volume":"51","author":"de Beer","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1194\/jlr.M012328","article-title":"ATP binding cassette G1-dependent cholesterol efflux during inflammation","volume":"52","author":"de Beer","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0185","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cytogfr.2015.12.010","article-title":"The cytokine-serum amyloid A-chemokine network","volume":"30","author":"De Buck","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/bs.acc.2019.01.002_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/ATVBAHA.108.178681","article-title":"HDL remodeling during the acute phase response","volume":"29","author":"Jahangiri","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/1440-1681.12888","article-title":"Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: spotlight on sphingosine-1-phosphate\/serum amyloid A ratio","volume":"45","author":"Egom","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOL.0000000000000331","article-title":"Serum amyloid A and atherosclerosis","volume":"27","author":"Getz","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0210","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.4049\/jimmunol.0902941","article-title":"Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model","volume":"184","author":"Connolly","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0215","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.4049\/jimmunol.177.8.5585","article-title":"Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis","volume":"177","author":"Lee","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0220","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/ard.2010.142240","article-title":"Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis","volume":"70","author":"Connolly","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.21518","article-title":"Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway","volume":"54","author":"Mullan","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2019.01.002_bb0230","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1074\/jbc.M500490200","article-title":"Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria","volume":"280","author":"Hari-Dass","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0235","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","article-title":"Serum amyloid A is an innate immune opsonin for Gram-negative bacteria","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2019.01.002_bb0240","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1128\/JVI.02627-06","article-title":"Human serum amyloid A protein inhibits hepatitis C virus entry into cells","volume":"81","author":"Cai","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0245","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/hep.21406","article-title":"Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system","volume":"44","author":"Lavie","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2019.01.002_bb0250","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3748\/wjg.14.574","article-title":"Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice","volume":"14","author":"Sidorkiewicz","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0255","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jlb.67.3.381","article-title":"Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity","volume":"67","author":"Badolato","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0260","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.74.9.4025","article-title":"Amyloid protein SAA is associated with high density lipoprotein from human serum","volume":"74","author":"Benditt","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2019.01.002_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1982.tb22136.x","article-title":"SAA, an apoprotein of HDL: its structure and function","volume":"389","author":"Benditt","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2019.01.002_bb0270","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.3760\/cma.j.issn.0366-6999.20130400","article-title":"The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease","volume":"126","author":"Wang","year":"2013","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/bs.acc.2019.01.002_bb0275","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1073\/pnas.78.8.4718","article-title":"Induction of hepatic synthesis of serum amyloid A protein and actin","volume":"78","author":"Morrow","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2019.01.002_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-4838(96)00227-0","article-title":"Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse","volume":"1339","author":"Lindhorst","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.acc.2019.01.002_bb0285","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI110847","article-title":"Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance","volume":"71","author":"Hoffman","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0005-2760(90)90030-2","article-title":"Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis","volume":"1043","author":"Tape","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.acc.2019.01.002_bb0295","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.mehy.2005.10.018","article-title":"Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A","volume":"66","author":"Manley","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/bs.acc.2019.01.002_bb0300","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1194\/jlr.E005454","article-title":"The acute phase response inhibits reverse cholesterol transport","volume":"51","author":"Feingold","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0305","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-90-481-8622-8_7","article-title":"High density lipoprotein structure-function and role in reverse cholesterol transport","volume":"51","author":"Lund-Katz","year":"2010","journal-title":"Subcell. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/13506120600877201","article-title":"The path of murine serum amyloid A through peritoneal macrophages","volume":"13","author":"Kinkley","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/bs.acc.2019.01.002_bb0315","first-page":"778","article-title":"Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function","volume":"66","author":"Kisilevsky","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003867","article-title":"Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages","volume":"3","author":"Tam","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb0325","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar3849","article-title":"Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1beta production from human synovial fibroblasts","volume":"14","author":"Migita","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/bs.acc.2019.01.002_bb0330","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0335","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4049\/jimmunol.1100500","article-title":"Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice","volume":"187","author":"Ather","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0345","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0350","first-page":"424","article-title":"Serum amyloid A (SAA) activates human mast cells which leads into degradation of SAA and generation of an amyloidogenic SAA fragment","volume":"2006","author":"Niemi","year":"1762","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.acc.2019.01.002_bb0355","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0049-0172(96)80041-2","article-title":"Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis","volume":"26","author":"Badolato","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/bs.acc.2019.01.002_bb0360","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.181.1.22","article-title":"Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A","volume":"181","author":"Cheng","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0365","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood-2008-03-139923","article-title":"Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2","volume":"113","author":"He","year":"2009","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2019.01.002_bb0370","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1189\/jlb.0407203","article-title":"Is serum amyloid A an endogenous TLR4 agonist?","volume":"83","author":"Sandri","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0375","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.180.1.203","article-title":"Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes","volume":"180","author":"Badolato","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/eji.201444818","article-title":"Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines","volume":"45","author":"Gouwy","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0385","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.105.022103","article-title":"Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes","volume":"70","author":"Lee","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0390","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3A0315-085R","article-title":"Serum amyloid A1alpha induces paracrine IL-8\/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils","volume":"98","author":"De Buck","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0395","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.4049\/jimmunol.181.6.4332","article-title":"Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes","volume":"181","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0400","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-3083.1998.00394.x","article-title":"Human serum amyloid A has cytokine-like properties","volume":"48","author":"Patel","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0405","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.155.3.1184","article-title":"A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion","volume":"155","author":"Xu","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0410","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molimm.2014.02.011","article-title":"Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation","volume":"59","author":"Nguyen","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0415","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2010-11-318832","article-title":"Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways","volume":"117","author":"Nguyen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2019.01.002_bb0420","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-2143(98)90112-3","article-title":"Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils","volume":"132","author":"Gatt","year":"1998","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0425","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0006-291X(91)90397-P","article-title":"Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein","volume":"176","author":"Linke","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb0430","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.128.6.2390","article-title":"SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction","volume":"128","author":"Aldo-Benson","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0435","first-page":"180","article-title":"Serum amyloid A, an acute phase protein, inhibits platelet activation","volume":"116","author":"Zimlichman","year":"1990","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0440","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/CCLM.1999.063","article-title":"Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness","volume":"37","author":"Yamada","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"issue":"Pt 3","key":"10.1016\/bs.acc.2019.01.002_bb0445","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/000456329303000309","article-title":"A rapid enzyme-linked immunosorbent assay for serum amyloid A using sequence-specific antibodies","volume":"30","author":"Casl","year":"1993","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0450","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/000456329303000112","article-title":"A rapid method for measuring serum amyloid A protein by latex agglutination nephelometric immunoassay","volume":"30","author":"Yamada","year":"1993","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0455","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-1759(83)90149-7","article-title":"Quantitative radial immunodiffusion assay for serum amyloid A protein","volume":"59","author":"Chambers","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/bs.acc.2019.01.002_bb0460","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2362.1996.159291.x","article-title":"Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice","volume":"26","author":"Malle","year":"1996","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb0465","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"Buck","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0470","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"10.1016\/bs.acc.2019.01.002_bb0475","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jcb.21472","article-title":"Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines","volume":"103","author":"Kovacevic","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0480","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1369\/jhc.2010.956821","article-title":"Expression of serum amyloid A in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis","volume":"58","author":"Urieli-Shoval","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0485","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/eji.200323985","article-title":"Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells","volume":"33","author":"Thorn","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13506129409148635","article-title":"Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis","volume":"1","author":"Husby","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/bs.acc.2019.01.002_bb0495","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-3083.1997.d01-108.x","article-title":"Generation and characterization of rat monoclonal antibodies against human serum amyloid A","volume":"46","author":"Yamada","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0500","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2407-12-365","article-title":"Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2019.01.002_bb0505","first-page":"1789","article-title":"Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus","volume":"35","author":"Rho","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0510","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.25009","article-title":"Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis","volume":"61","author":"Rho","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2019.01.002_bb0515","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0520","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/cncr.24838","article-title":"Serum amyloid A: a novel biomarker for endometrial cancer","volume":"116","author":"Cocco","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/bs.acc.2019.01.002_bb0525","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.36.7.798","article-title":"Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease","volume":"36","author":"Raynes","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0530","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1373\/clinchem.2017.279372","article-title":"Copy number variations in serum amyloid A play a role in the determination of its individual baseline concentrations","volume":"64","author":"Zhang","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0535","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-3083.1984.tb00919.x","article-title":"Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases","volume":"19","author":"Weinstein","year":"1984","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0540","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7326\/0003-4819-91-3-383","article-title":"Serum amyloid A to monitor cancer dissemination","volume":"91","author":"Rosenthal","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0545","series-title":"Use of Anticoagulants in Diagnostic Laboratory Investigations and Stability of Blood, Plasma and Serum Samples","author":"Ehret","year":"2002"},{"key":"10.1016\/bs.acc.2019.01.002_bb0550","first-page":"1","article-title":"Amyloid-related serum protein (SAA) during and after pregnancy in healthy women and women with rheumatic disease","volume":"93","author":"Ostensen","year":"1985","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. C"},{"key":"10.1016\/bs.acc.2019.01.002_bb0555","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00011-010-0163-y","article-title":"Association between serum amyloid A and obesity: a meta-analysis and systematic review","volume":"59","author":"Zhao","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(98)00057-X","article-title":"The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study","volume":"214","author":"Poole","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/bs.acc.2019.01.002_bb0565","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/cs0680233","article-title":"Comparative study of serum amyloid A protein and C-reactive protein in disease","volume":"68","author":"Maury","year":"1985","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/bs.acc.2019.01.002_bb0570","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/clinchem\/40.7.1284","article-title":"Rapid automated enzyme immunoassay of serum amyloid A","volume":"40","author":"Wilkins","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0575","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/clinchem\/39.2.293","article-title":"Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases","volume":"39","author":"Nakayama","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0580","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0585","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/1354750X.2011.607189","article-title":"Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times","volume":"16","author":"Takata","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/bs.acc.2019.01.002_bb0590","first-page":"163","article-title":"Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis","volume":"89","author":"Mayer","year":"2002","journal-title":"Br. J. Surg."},{"key":"10.1016\/bs.acc.2019.01.002_bb0595","first-page":"58","article-title":"Serum amyloid A in the assessment of early inflammatory arthritis","volume":"27","author":"Cunnane","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0600","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3748\/wjg.14.675","article-title":"Severe acute pancreatitis: pathogenetic aspects and prognostic factors","volume":"14","author":"Al Mofleh","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0605","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00365540050165848","article-title":"C-reactive protein and serum amyloid A protein in neonatal infections","volume":"32","author":"Pizzini","year":"2000","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0610","first-page":"1901","article-title":"The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection","volume":"10","author":"Casl","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2019.01.002_bb0615","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00007890-198311000-00006","article-title":"Serum amyloid A protein: a sensitive indicator of renal allograft rejection in humans","volume":"36","author":"Maury","year":"1983","journal-title":"Transplantation"},{"key":"10.1016\/bs.acc.2019.01.002_bb0620","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/12.1.161","article-title":"Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection","volume":"12","author":"Hartmann","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2019.01.002_bb0625","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.jp.7211682","article-title":"Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis","volume":"27","author":"Arnon","year":"2007","journal-title":"J. Perinatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0630","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.7754\/Clin.Lab.2014.140209","article-title":"Diabetic foot disease: grading inflammation by apolipoprotein A-I, C-reactive protein and serum amyloid A","volume":"60","author":"Wang","year":"2014","journal-title":"Clin. Lab."},{"key":"10.1016\/bs.acc.2019.01.002_bb0635","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/jp.2008.207","article-title":"Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants","volume":"29","author":"\u00c7etinkaya","year":"2008","journal-title":"J. Perinatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0640","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/phar.2112","article-title":"Procalcitonin monitoring as a guide for antimicrobial therapy: a review of current literature","volume":"38","author":"Covington","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/bs.acc.2019.01.002_bb0645","first-page":"267","article-title":"Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis","volume":"59","author":"Zuppa","year":"2007","journal-title":"Minerva Pediatr."},{"key":"10.1016\/bs.acc.2019.01.002_bb0650","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1586\/erm.11.26","article-title":"Early diagnosis of sepsis using serum biomarkers","volume":"11","author":"Chan","year":"2011","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/bs.acc.2019.01.002_bb0655","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/adc.68.2.210","article-title":"Serum amyloid A protein in acute viral infections","volume":"68","author":"Miwata","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/bs.acc.2019.01.002_bb0660","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1651-2227.1983.tb09831.x","article-title":"Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis","volume":"72","author":"Marhaug","year":"1983","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/bs.acc.2019.01.002_bb0665","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jinf.2008.06.009","article-title":"Toll-like receptor 2 expression level on monocytes in patients with viral infections: monitoring infection severity","volume":"57","author":"Kajiya","year":"2008","journal-title":"J. Infect."},{"key":"10.1016\/bs.acc.2019.01.002_bb0670","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jinf.2011.12.019","article-title":"The use of PCT, CRP, IL-6 and SAA in critically ill patients for an early distinction between candidemia and Gram positive\/negative bacteremia","volume":"64","author":"Fu","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/bs.acc.2019.01.002_bb0675","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/JCM.00655-10","article-title":"Use of plasma procalcitonin levels as an adjunct to clinical microbiology","volume":"48","author":"Gilbert","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0680","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations","volume":"36","author":"Becker","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0685","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/PEC.0b013e3181c399df","article-title":"Procalcitonin as a marker of severe bacterial infection in children in the emergency department","volume":"26","author":"Deis","year":"2010","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/bs.acc.2019.01.002_bb0690","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.inf.0000091360.11784.21","article-title":"Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker","volume":"22","author":"Fernandez Lopez","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/bs.acc.2019.01.002_bb0695","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/jcp.38.3.312","article-title":"Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza","volume":"38","author":"Whicher","year":"1985","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0700","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s15010-008-7374-y","article-title":"The role of procalcitonin in febrile neutropenic patients: review of the literature","volume":"36","author":"Sakr","year":"2008","journal-title":"Infection"},{"key":"10.1016\/bs.acc.2019.01.002_bb0705","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10096-005-1312-z","article-title":"Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections","volume":"24","author":"Petrikkos","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0710","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00383-010-2635-0","article-title":"The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants","volume":"26","author":"Cetinkaya","year":"2010","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/bs.acc.2019.01.002_bb0715","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccc.2006.03.003","article-title":"Markers for sepsis diagnosis: what is useful?","volume":"22","author":"Reinhart","year":"2006","journal-title":"Crit. Care Clin."},{"key":"10.1016\/bs.acc.2019.01.002_bb0720","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.7314\/APJCP.2014.15.24.10713","article-title":"Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma","volume":"15","author":"Ni","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/bs.acc.2019.01.002_bb0725","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1159\/000438474","article-title":"Serum amyloid A-positive hepatocellular neoplasm: a new type of tumor arising in patients with advanced alcoholic disease","volume":"33","author":"Sasaki","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0730","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jcb.21443","article-title":"Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma","volume":"103","author":"He","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0735","article-title":"Serum amyloid A induces inflammation, proliferation and cell death in activated hepatic stellate cells","volume":"11","author":"Avila","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb0740","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/his.13016","article-title":"Serum amyloid A immunohistochemical staining patterns in hepatitis","volume":"69","author":"Piotti","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/bs.acc.2019.01.002_bb0745","first-page":"582","article-title":"Conformational flexibility of the serum amyloid precursor SAA","volume":"57","author":"Sipe","year":"1976","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0750","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150893","article-title":"Serum amyloid A induces inflammation, proliferation and cell death in activated hepatic stellate cells","volume":"11","author":"Siegmund","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb0760","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2019.01.002_bb0765","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/art.20301","article-title":"Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis","volume":"50","author":"O'Hara","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2019.01.002_bb0770","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/ar78","article-title":"Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue","volume":"2","author":"O'Hara","year":"2000","journal-title":"Arthritis Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0775","first-page":"785","article-title":"Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells","volume":"26","author":"Kumon","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066769","article-title":"Acute-phase serum amyloid A in osteoarthritis: regulatory mechanism and proinflammatory properties","volume":"8","author":"de Seny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb0785","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.42.6.665","article-title":"Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity","volume":"42","author":"Chambers","year":"1983","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0790","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.41.3.268","article-title":"Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus","volume":"41","author":"Maury","year":"1982","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0795","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/ibd.21263","article-title":"Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis","volume":"16","author":"Noble","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0800","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/gut.2008.148395","article-title":"Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis","volume":"57","author":"Noble","year":"2008","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2019.01.002_bb0805","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.autrev.2006.03.006","article-title":"Serum amyloid A in autoimmune thrombosis","volume":"6","author":"Sodin-Semrl","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2019.01.002_bb0810","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.dld.2017.12.010","article-title":"Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease\u2014possible biomarker for evaluating mucosal healing","volume":"50","author":"Ishihara","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0815","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MIB.0000000000000991","article-title":"Serum amyloid A as a surrogate marker for mucosal and histologic inflammation in patients with Crohn\u02bcs disease","volume":"23","author":"Yarur","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb0820","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.0000124718.99562.91","article-title":"Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population","volume":"109","author":"Helmersson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2019.01.002_bb0825","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/dc08-0036","article-title":"Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project","volume":"31","author":"Ley","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2019.01.002_bb0830","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1900\/RDS.2007.4.98","article-title":"Association between low-grade systemic inflammation and type 2 diabetes mellitus among men and women from the ATTICA study","volume":"4","author":"Pitsavos","year":"2007","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/bs.acc.2019.01.002_bb0835","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db05-1320","article-title":"Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study","volume":"55","author":"Herder","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/bs.acc.2019.01.002_bb0840","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0009-9120(94)00044-V","article-title":"Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus","volume":"27","author":"Kumon","year":"1994","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb0845","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2337\/dc12-1514","article-title":"Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4\/F4 study","volume":"36","author":"Marzi","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2019.01.002_bb0850","doi-asserted-by":"crossref","first-page":"230837","DOI":"10.1155\/2008\/230837","article-title":"Acute-phase serum amyloid A as a marker of insulin resistance in mice","volume":"2008","author":"Scheja","year":"2008","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0855","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00011-010-0163-y","article-title":"Association between serum amyloid A and obesity: a meta-analysis and systematic review","volume":"59","author":"Zhao","year":"2010","journal-title":"Inflamm. Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0860","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00125-004-1654-6","article-title":"Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition","volume":"48","author":"Poitou","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/bs.acc.2019.01.002_bb0865","first-page":"59","article-title":"Development of main disturbances of hemostasis in patients with obesity","volume":"52","author":"Shishkova","year":"2012","journal-title":"Kardiologiia"},{"key":"10.1016\/bs.acc.2019.01.002_bb0870","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1038\/nutd.2017.10","article-title":"Microglia activation due to obesity programs metabolic failure leading to type two diabetes","volume":"7","author":"Maldonado-Ruiz","year":"2017","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/bs.acc.2019.01.002_bb0875","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jdiacomp.2016.07.018","article-title":"Serum amyloid A and risk of death and end-stage renal disease in diabetic kidney disease","volume":"30","author":"Dieter","year":"2016","journal-title":"J. Diabet. Complications"},{"key":"10.1016\/bs.acc.2019.01.002_bb0880","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/labinvest.2015.38","article-title":"Serum amyloid A and inflammation in diabetic kidney disease and podocytes","volume":"95","author":"Anderberg","year":"2015","journal-title":"Lab. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030287","article-title":"Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications","volume":"3","author":"Yang","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0890","first-page":"3007","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"Zewinger","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2019.01.002_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/1314864","article-title":"Type 2 diabetes in young females results in increased serum amyloid A and changes to features of high density lipoproteins in both HDL2 and HDL3","volume":"2017","author":"Griffiths","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0900","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb0905","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1053\/euhj.1998.1309","article-title":"Risk factors for coronary heart disease and acute-phase proteins. A population-based study","volume":"20","author":"Danesh","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/bs.acc.2019.01.002_bb0910","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/jc.2004-1011","article-title":"Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects","volume":"90","author":"O'Brien","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.01.002_bb0915","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2008-0701","article-title":"Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study","volume":"94","author":"Lee","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.01.002_bb0920","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb0925","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.91.8.3186","article-title":"Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function","volume":"91","author":"Meek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2019.01.002_bb0930","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MOL.0b013e3283488c39","article-title":"Serum amyloid A in atherosclerosis","volume":"22","author":"King","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0935","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbrc.2013.03.002","article-title":"Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation","volume":"433","author":"Lee","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb0940","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1194\/jlr.M054015","article-title":"A brief elevation of serum amyloid A is sufficient to increase atherosclerosis","volume":"56","author":"Thompson","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb0945","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2353\/ajpath.2008.080201","article-title":"Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner","volume":"173","author":"Wilson","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0950","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/clc.4960210909","article-title":"Serum amyloid type A may be a predictor of restenosis","volume":"21","author":"Blum","year":"1998","journal-title":"Clin. Cardiol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0955","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.24735","article-title":"Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview","volume":"61","author":"Obici","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2019.01.002_bb0960","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2019.01.002_bb0965","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"Real de Asua","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0970","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/pmic.200300514","article-title":"Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption\/ionization-time of flight spectra analysis","volume":"3","author":"Howard","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/bs.acc.2019.01.002_bb0975","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/jcp.39.7.794","article-title":"Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis","volume":"39","author":"Biran","year":"1986","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0980","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jprot.2012.06.022","article-title":"SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors","volume":"76 Spec No","author":"Milan","year":"2012","journal-title":"J. Proteomics"},{"key":"10.1016\/bs.acc.2019.01.002_bb0985","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.eururo.2009.08.017","article-title":"Editorial comment on: inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome","volume":"57","author":"Axelson","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/bs.acc.2019.01.002_bb0990","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.autrev.2006.03.006","article-title":"Serum amyloid A in autoimmune thrombosis","volume":"6","author":"Sodin-\u0160emrl","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2019.01.002_bb0995","first-page":"535","article-title":"Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts","volume":"78","author":"Migita","year":"1998","journal-title":"Lab. Invest."},{"key":"10.1016\/bs.acc.2019.01.002_bb1000","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-291X(05)80107-X","article-title":"The N-terminal segment of protein AA determines its fibrillogenic property","volume":"182","author":"Westermark","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb1005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1100\/tsw.2011.64","article-title":"Recent insights into the pathogenesis of type AA amyloidosis","volume":"11","author":"van der Hilst","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/bs.acc.2019.01.002_bb1010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/kei112","article-title":"Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/bs.acc.2019.01.002_bb1015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2006.063834","volume":"66","author":"Matsui","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb1020","first-page":"375","article-title":"Laboratory characteristics of a cohort of patients with early rheumatoid arthritis","volume":"50","author":"da Mota","year":"2010","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12016-007-8018-1","article-title":"Does the presence of anti-CCP autoantibodies and their serum levels influence the severity and activity in rheumatoid arthritis patients?","volume":"34","author":"Papadopoulos","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0307-742X(21)00449-5","article-title":"The role of the laboratory in rheumatology. Rheumatoid factors","volume":"9","author":"Egeland","year":"1983","journal-title":"Clin Rheum. Dis."},{"key":"10.1016\/bs.acc.2019.01.002_bb1035","first-page":"183","article-title":"A population study of rheumatoid factor in Iceland. A 5-year follow-up of 50 women with rheumatoid factor (RF)","volume":"7","author":"Thorsteinsson","year":"1975","journal-title":"Ann. Clin. Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb1040","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3892\/mmr.2014.2804","article-title":"Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis","volume":"11","author":"Shen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/bs.acc.2019.01.002_bb1045","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/ajg.2014.242","article-title":"Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: data from ULTRA 1, 2, and 3","volume":"109","author":"Colombel","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Froslie","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acc.2019.01.002_bb1055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1469-1809.2006.00272.x","article-title":"Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia","volume":"70","author":"Suk Danik","year":"2006","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/bs.acc.2019.01.002_bb1060","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-017-0613-8","article-title":"The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation","volume":"16","author":"Ebtehaj","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1065","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.1016\/S0021-9258(18)67562-3","article-title":"Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition","volume":"261","author":"Coetzee","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb1070","doi-asserted-by":"crossref","first-page":"351601","DOI":"10.1155\/2015\/351601","article-title":"A cross-sectional study demonstrating increased serum amyloid A related inflammation in high-density lipoproteins from subjects with type 1 diabetes mellitus and how this association was augmented by poor glycaemic control","volume":"2015","author":"McEneny","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb1075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.thromres.2007.10.016","article-title":"Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G\/5G polymorphism","volume":"122","author":"Sola","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb1080","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1161\/01.CIR.0000130640.77501.79","article-title":"Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences","volume":"109","author":"Greenfield","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2019.01.002_bb1085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-07-0721","article-title":"Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study","volume":"158","author":"Madsen","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1090","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2019.01.002_bb1095","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/diabetes.54.8.2277","article-title":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss","volume":"54","author":"Cancello","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/bs.acc.2019.01.002_bb1100","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1210\/jc.2004-1830","article-title":"A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A","volume":"90","author":"Sjoholm","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.01.002_bb1105","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1210\/jc.2008-2040","article-title":"Role of serum amyloid A in adipocyte-macrophage cross talk and adipocyte cholesterol efflux","volume":"94","author":"Poitou","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.01.002_bb1110","first-page":"847","article-title":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid","volume":"83","author":"Fried","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.01.002_bb1115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/bs.acc.2019.01.002_bb1120","first-page":"650","article-title":"Human serum amyloid A genes are expressed in monocyte\/macrophage cell lines","volume":"145","author":"Urieli-Shoval","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2019.01.002_bb1130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/oby.2006.65","article-title":"Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population","volume":"14","author":"Liu","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/bs.acc.2019.01.002_bb1135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(02)00371-4","article-title":"Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes","volume":"166","author":"Leinonen","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.acc.2019.01.002_bb1140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb1145","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/01.CIR.0000115516.54550.B1","article-title":"Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"Johnson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2019.01.002_bb1150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1503\/cmaj.050880","article-title":"Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort","volume":"174","author":"Lee","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/bs.acc.2019.01.002_bb1155","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1194\/jlr.M000323","article-title":"Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2)","volume":"51","author":"Annema","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb1160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/ATVBAHA.113.303044","article-title":"Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice","volume":"34","author":"Hewing","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.33549\/physiolres.932680","article-title":"Reverse transport of cholesterol is the reason for resistance to development of atherosclerosis in Prague Hereditary Hypercholesterolemic (PHHC) rat","volume":"63","author":"Schmiedtova","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb1170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/1440-1681.12888","article-title":"Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: spotlight on sphingosine-1-phosphate\/serum amyloid A ratio","volume":"45","author":"Egom","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOL.0000000000000331","article-title":"Serum amyloid A and atherosclerosis","volume":"27","author":"Getz","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/clinchem\/43.1.193","article-title":"Serum amyloid A remains at physiological concentrations in coronary atherosclerosis","volume":"43","author":"Yamada","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb1185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2019.01.002_bb1190","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5551\/jat.No968","article-title":"Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study","volume":"16","author":"Carty","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/bs.acc.2019.01.002_bb1195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013997","article-title":"Polymorphisms in the SAA1\/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey","volume":"5","author":"Xie","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb1200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/08037051.2011.566244","article-title":"Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects","volume":"20","author":"Xie","year":"2011","journal-title":"Blood Press."},{"key":"10.1016\/bs.acc.2019.01.002_bb1205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cell.2012.11.043","article-title":"Gene copy-number alterations: a cost-benefit analysis","volume":"152","author":"Tang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2019.01.002_bb1210","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(09)60249-X","article-title":"Genomic copy number variation, human health, and disease","volume":"374","author":"Wain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2019.01.002_bb1215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020712-163913","article-title":"AA amyloidosis: pathogenesis and targeted therapy","volume":"10","author":"Westermark","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1258\/acb.2011.011225","article-title":"Amyloidosis","volume":"49","author":"Pinney","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb1225","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/39.10.1940305","article-title":"A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis","volume":"39","author":"Snow","year":"1991","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/bs.acc.2019.01.002_bb1230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2017.12.016","article-title":"Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A","volume":"639","author":"Tanaka","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/bs.acc.2019.01.002_bb1235","doi-asserted-by":"crossref","first-page":"E6507","DOI":"10.1073\/pnas.1707120114","article-title":"Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis","volume":"114","author":"Jayaraman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2019.01.002_bb1240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.chemphyslip.2016.11.004","article-title":"Effect of lipid environment on amyloid fibril formation of human serum amyloid A","volume":"202","author":"Tanaka","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/bs.acc.2019.01.002_bb1245","doi-asserted-by":"crossref","first-page":"25669","DOI":"10.1074\/jbc.M112.363895","article-title":"Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation","volume":"287","author":"Noborn","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb1250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/13506129.2011.597464","article-title":"Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis","volume":"18","author":"Kluve-Beckerman","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/bs.acc.2019.01.002_bb1255","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autrev.2012.07.016","article-title":"Amyloidosis in autoinflammatory syndromes","volume":"12","author":"Obici","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2019.01.002_bb1260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00018-008-8321-x","article-title":"Serum amyloid A: an acute-phase protein involved in tumour pathogenesis","volume":"66","author":"Malle","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.acc.2019.01.002_bb1265","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.12196","article-title":"Serum amyloid A1 in combination with integrin alphaVbeta3 increases glioblastoma cells mobility and progression","author":"Lin","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1270","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/onc.2014.12","article-title":"SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma","volume":"34","author":"Lung","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2019.01.002_bb1275","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function","volume":"207","author":"Sander","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2019.01.002_bb1280","doi-asserted-by":"crossref","first-page":"149185","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/bs.acc.2019.01.002_bb1285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/s10165-006-0500-8","article-title":"SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis","volume":"16","author":"Ajiro","year":"2006","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1290","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s004399900150","article-title":"Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis","volume":"105","author":"Moriguchi","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/bs.acc.2019.01.002_bb1295","doi-asserted-by":"crossref","first-page":"e40263","DOI":"10.1371\/journal.pone.0040263","article-title":"Serum uric acid levels are associated with polymorphism in the SAA1 gene in Chinese subjects","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb1300","article-title":"The contribution of SAA1 polymorphisms to familial Mediterranean fever susceptibility in the Japanese population","volume":"8","author":"Speletas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.01.002_bb1305","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.atherosclerosis.2013.01.003","article-title":"Variant screening of the serum amyloid A1 gene and functional study of the p.Gly90Asp variant for its role in atherosclerosis","volume":"227","author":"Leow","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.acc.2019.01.002_bb1310","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/ken371","article-title":"Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis","volume":"47","author":"van der Hilst","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/bs.acc.2019.01.002_bb1315","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/ndt\/17.7.1212","article-title":"Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks","volume":"17","author":"Dode","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/bs.acc.2019.01.002_bb1320","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/prca.201600028","article-title":"Acute phase proteins as promising biomarkers: perspectives and limitations for human and veterinary medicine","volume":"10","author":"Schr\u00f6dl","year":"2016","journal-title":"Proteomics. Clin. Appl."},{"key":"10.1016\/bs.acc.2019.01.002_bb1325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tvjl.2010.04.009","article-title":"Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine","volume":"185","author":"Eckersall","year":"2010","journal-title":"Vet. J."},{"key":"10.1016\/bs.acc.2019.01.002_bb1330","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tvjl.2012.05.007","article-title":"Evaluation of an automated assay based on monoclonal anti-human serum amyloid A (SAA) antibodies for measurement of canine, feline, and equine SAA","volume":"194","author":"Christensen","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/bs.acc.2019.01.002_bb1335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1939-165X.2005.tb00019.x","article-title":"Acute phase proteins in dogs and cats: current knowledge and future perspectives","volume":"34","author":"Ceron","year":"2005","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1340","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0264-410X(96)00232-0","article-title":"Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease","volume":"15","author":"Yule","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/bs.acc.2019.01.002_bb1345","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006404902214","article-title":"A comparison of the concentrations of C-reactive protein and alpha1-acid glycoprotein in the serum of young and adult dogs with acute inflammation","volume":"25","author":"Hayashi","year":"2001","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/bs.acc.2019.01.002_bb1350","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1090-0233(03)00055-8","article-title":"Changes in some acute phase protein and immunoglobulin concentrations in cats affected by feline infectious peritonitis or exposed to feline coronavirus infection","volume":"167","author":"Giordano","year":"2004","journal-title":"Vet. J."},{"key":"10.1016\/bs.acc.2019.01.002_bb1355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-2427(99)00012-4","article-title":"Changes in concentrations of serum amyloid a protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery","volume":"68","author":"Kajikawa","year":"1999","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/bs.acc.2019.01.002_bb1360","doi-asserted-by":"crossref","first-page":"10271","DOI":"10.1016\/S0021-9258(18)34015-8","article-title":"The acute phase response of plasma protein synthesis during experimental inflammation","volume":"257","author":"Schreiber","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2019.01.002_bb1365","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1292\/jvms.65.545","article-title":"Evaluation of feline serum amyloid A (SAA) as an inflammatory marker","volume":"65","author":"Sasaki","year":"2003","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/bs.acc.2019.01.002_bb1370","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1292\/jvms.70.1247","article-title":"Verification of measurement of the feline serum amyloid A (SAA) concentration by human SAA turbidimetric immunoassay and its clinical application","volume":"70","author":"Tamamoto","year":"2008","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/bs.acc.2019.01.002_bb1375","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/BF03547012","article-title":"The acute phase protein serum amyloid A (SAA) as an inflammatory marker in equine influenza virus infection","volume":"40","author":"Hulten","year":"1999","journal-title":"Acta Vet. Scand."},{"key":"10.1016\/bs.acc.2019.01.002_bb1380","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1292\/jvms.69.827","article-title":"Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition of horses with bacterial pneumonia","volume":"69","author":"Hobo","year":"2007","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/bs.acc.2019.01.002_bb1385","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1939-1676.2012.00993.x","article-title":"Markers of systemic inflammation in horses with heaves","volume":"26","author":"Lavoie-Lamoureux","year":"2012","journal-title":"J. Vet. Intern. Med."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242319300022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242319300022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:38:31Z","timestamp":1758742711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242319300022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128171790"],"references-count":276,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2019.01.002","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}